Evidence map›Paper›PMID 35593465›Full record

ArticleActa biochimica et biophysica Sinica2022

Ginsenoside Rh2 inhibits breast cancer cell growth via ERβ-TNFα pathway.

Kunjian Peng, Tiao Luo, Jijia Li, Jingjia Huang, Zizeng Dong, Jia Liu, Chaoqiong Pi, Zizeng Zou, Qin Gu, Ousheng Liu and 2 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta biochimica et biophysica Sinica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Potential ofChinese herbal medicines · 2025
    Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Kunjian PengDepartment of Biochemistry and Molecular Biology, Hunan Province Key Laboratory of Basic and Applied Hematology & Hunan Key Laboratory of Animal Models for Human Diseases, School of Life Sciences, Central South University, Changsha 410008, China.
Tiao LuoHunan Key Laboratory of Oral Health Research & Xiangya Stomatological Hospital & Xiangya School of Stomatology, Central South University, Changsha 410008, China.
Jijia LiCenter of Stomatology, Xiangya Hospital, Central South University, Changsha 410008, China.
Jingjia HuangDepartment of Biochemistry and Molecular Biology, Hunan Province Key Laboratory of Basic and Applied Hematology & Hunan Key Laboratory of Animal Models for Human Diseases, School of Life Sciences, Central South University, Changsha 410008, China.
Zizeng DongDepartment of Cell and Cancer Biology, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43614, USA.
Jia LiuDepartment of Biochemistry and Molecular Biology, Hunan Province Key Laboratory of Basic and Applied Hematology & Hunan Key Laboratory of Animal Models for Human Diseases, School of Life Sciences, Central South University, Changsha 410008, China.
Chaoqiong PiDepartment of Biochemistry and Molecular Biology, Hunan Province Key Laboratory of Basic and Applied Hematology & Hunan Key Laboratory of Animal Models for Human Diseases, School of Life Sciences, Central South University, Changsha 410008, China.
Zizeng ZouDepartment of Biochemistry and Molecular Biology, Hunan Province Key Laboratory of Basic and Applied Hematology & Hunan Key Laboratory of Animal Models for Human Diseases, School of Life Sciences, Central South University, Changsha 410008, China.
Qin GuDepartment of Biochemistry and Molecular Biology, Hunan Province Key Laboratory of Basic and Applied Hematology & Hunan Key Laboratory of Animal Models for Human Diseases, School of Life Sciences, Central South University, Changsha 410008, China.
Ousheng LiuHunan Key Laboratory of Oral Health Research & Xiangya Stomatological Hospital & Xiangya School of Stomatology, Central South University, Changsha 410008, China.
Jian-Ting ZhangDepartment of Cell and Cancer Biology, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43614, USA.
Zhi-Yong LuoDepartment of Biochemistry and Molecular Biology, Hunan Province Key Laboratory of Basic and Applied Hematology & Hunan Key Laboratory of Animal Models for Human Diseases, School of Life Sciences, Central South University, Changsha 410008, China.
Central South University · CNUniversity of Toledo · USXiangya Hospital Central South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ginsenoside Rh2 is one of rare panaxidiols extracted from

Indexed as

Breast NeoplasmsGinsenosidesAnimalsApoptosisApoptosis Regulatory ProteinsCell ProliferationEstrogen Receptor alphaEstrogen Receptor betaFemaleHumansLigandsMiceReceptors, EstrogenRNA, MessengerTumor Necrosis Factor-alphaApoptosis Regulatory ProteinsEstrogen Receptor alphaEstrogen Receptor betaginsenoside Rh2GinsenosidesLigandsReceptors, EstrogenRNA, MessengerTumor Necrosis Factor-alphaapoptosisbreast cancerestrogen receptorginsenoside Rh2TNFα

Identifiers

PMID35593465
PMCPMC9828196
OpenAlexW4281260662

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.